Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05394025 · ClinicalTrials.gov registry record
COVID-19 Observational Research Collaboratory
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 479
- Enrollment target
NCT05394025: Completed study, sponsored by VA Office of Research and Development.
NCT05394025 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 479 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05394025 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 479 participants
- Enrollment target
Study Summary
This study aims to examine the long-term outcomes in Veterans infected and uninfected with SARS-CoV-2 using electronic health record information and structured surveys.
Primary Outcome
Measures level of disability on a scale from 0 - 14, where higher values are considered a worse outcome. Multiple survey timepoints will allow us to assess change in disability over time. The score consists of 14 questions about activities of daily living. The I/ADL score is a sum total of reported limitations ranging from 0 (no limitations reported) to 14 (limitations in all activities asked reported).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 479 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2024-06-01 |
What the finished NCT05394025 record still lists
NCT05394025 is an observational study that tracks outcomes without assigning an intervention. The registered 479 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05394025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05394025 about?
NCT05394025 is a clinical study titled "COVID-19 Observational Research Collaboratory". This study aims to examine the long-term outcomes in Veterans infected and uninfected with SARS-CoV-2 using electronic health record information and structured surveys.
What is the current status of trial NCT05394025?
This trial is currently completed. The enrollment target is 479 participants. The study started on 2022-05-18. Estimated completion is 2024-06-01.
Who is sponsoring clinical trial NCT05394025?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04221542 · 479 participants · Phase 1
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI